These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 28892135)

  • 1. Metabolically active CD4+ T cells expressing Glut1 and OX40 preferentially harbor HIV during in vitro infection.
    Palmer CS; Duette GA; Wagner MCE; Henstridge DC; Saleh S; Pereira C; Zhou J; Simar D; Lewin SR; Ostrowski M; McCune JM; Crowe SM
    FEBS Lett; 2017 Oct; 591(20):3319-3332. PubMed ID: 28892135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphism rs1385129 Within Glut1 Gene
    Masson JJR; Cherry CL; Murphy NM; Sada-Ovalle I; Hussain T; Palchaudhuri R; Martinson J; Landay AL; Billah B; Crowe SM; Palmer CS
    Front Immunol; 2018; 9():900. PubMed ID: 29867928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cells potently purge latent HIV-1 beyond TCR-stimulation, activating the PI3K-Akt-mTOR pathway.
    van Montfort T; van der Sluis R; Darcis G; Beaty D; Groen K; Pasternak AO; Pollakis G; Vink M; Westerhout EM; Hamdi M; Bakker M; van der Putten B; Jurriaans S; Prins JH; Jeeninga R; Thomas AAM; Speijer D; Berkhout B
    EBioMedicine; 2019 Apr; 42():97-108. PubMed ID: 30824386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of metabolic and mitochondrial dynamics in CD4+ and CD8+ T cells in virologically suppressed HIV-positive individuals on combination antiretroviral therapy.
    Masson JJR; Murphy AJ; Lee MKS; Ostrowski M; Crowe SM; Palmer CS
    PLoS One; 2017; 12(8):e0183931. PubMed ID: 28854263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dasatinib inhibits HIV-1 replication through the interference of SAMHD1 phosphorylation in CD4+ T cells.
    Bermejo M; López-Huertas MR; García-Pérez J; Climent N; Descours B; Ambrosioni J; Mateos E; Rodríguez-Mora S; Rus-Bercial L; Benkirane M; Miró JM; Plana M; Alcamí J; Coiras M
    Biochem Pharmacol; 2016 Apr; 106():30-45. PubMed ID: 26851491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A recombinant vesicular stomatitis virus encoding HIV-1 receptors and human OX40 ligand efficiently eliminates HIV-1-infected CD4-positive T cells expressing OX40.
    Tsuruno C; Okuma K; Takahashi Y; Tanaka R; Tanaka Y; Takahama Y; Hamaguchi Y; Hamaguchi I; Yamaguchi K
    Hum Immunol; 2011 Apr; 72(4):295-304. PubMed ID: 21262309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulators of Glucose Metabolism in CD4
    Palmer CS; Hussain T; Duette G; Weller TJ; Ostrowski M; Sada-Ovalle I; Crowe SM
    Int Rev Immunol; 2016 Nov; 35(6):477-488. PubMed ID: 26606199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
    Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
    J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of tyrosine kinase inhibitors during primary HIV-1 infection.
    Ambrosioni J; Coiras M; Alcamí J; Miró JM
    Expert Rev Anti Infect Ther; 2017 May; 15(5):421-423. PubMed ID: 28322065
    [No Abstract]   [Full Text] [Related]  

  • 10. Suppression of Glut1 and Glucose Metabolism by Decreased Akt/mTORC1 Signaling Drives T Cell Impairment in B Cell Leukemia.
    Siska PJ; van der Windt GJ; Kishton RJ; Cohen S; Eisner W; MacIver NJ; Kater AP; Weinberg JB; Rathmell JC
    J Immunol; 2016 Sep; 197(6):2532-40. PubMed ID: 27511728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Programmed Death-1 Inhibition of Phosphatidylinositol 3-Kinase/AKT/Mechanistic Target of Rapamycin Signaling Impairs Sarcoidosis CD4
    Celada LJ; Rotsinger JE; Young A; Shaginurova G; Shelton D; Hawkins C; Drake WP
    Am J Respir Cell Mol Biol; 2017 Jan; 56(1):74-82. PubMed ID: 27564547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased glucose metabolic activity is associated with CD4+ T-cell activation and depletion during chronic HIV infection.
    Palmer CS; Ostrowski M; Gouillou M; Tsai L; Yu D; Zhou J; Henstridge DC; Maisa A; Hearps AC; Lewin SR; Landay A; Jaworowski A; McCune JM; Crowe SM
    AIDS; 2014 Jan; 28(3):297-309. PubMed ID: 24335483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roscovitine suppresses CD4+ T cells and T cell-mediated experimental uveitis.
    Zhang Z; Liu Q; Leskov KS; Wu X; Duan J; Zhang GL; Hall M; Rosenbaum JT
    PLoS One; 2013; 8(11):e81154. PubMed ID: 24260551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of a small molecule agonist of phosphatidylinositol 3-kinase p110α that reactivates latent HIV-1.
    Doyon G; Sobolewski MD; Huber K; McMahon D; Mellors JW; Sluis-Cremer N
    PLoS One; 2014; 9(1):e84964. PubMed ID: 24489654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic activation of the PI3K/Akt pathway promotes cellular glucose uptake by downregulating the expression of thioredoxin-interacting protein.
    Hong SY; Yu FX; Luo Y; Hagen T
    Cell Signal; 2016 May; 28(5):377-383. PubMed ID: 26826652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirements for the functional expression of OX40 ligand on human activated CD4+ and CD8+ T cells.
    Kondo K; Okuma K; Tanaka R; Zhang LF; Kodama A; Takahashi Y; Yamamoto N; Ansari AA; Tanaka Y
    Hum Immunol; 2007 Jul; 68(7):563-71. PubMed ID: 17584577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of Glucose Uptake and Hexokinase Activity of Primary Human CD4+ T Cells in Response to Infection with HIV-1.
    Kavanagh Williamson M; Coombes N; Juszczak F; Athanasopoulos M; Khan MB; Eykyn TR; Srenathan U; Taams LS; Dias Zeidler J; Da Poian AT; Huthoff H
    Viruses; 2018 Mar; 10(3):. PubMed ID: 29518929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower CD4+ T lymphocyte nadirs may indicate limited immune reconstitution in HIV-1 infected individuals on potent antiretroviral therapy: analysis of immunophenotypic marker results of AACTG 5067.
    D'Amico R; Yang Y; Mildvan D; Evans SR; Schnizlein-Bick CT; Hafner R; Webb N; Basar M; Zackin R; Jacobson MA
    J Clin Immunol; 2005 Mar; 25(2):106-15. PubMed ID: 15821887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass Cytometry Analysis Reveals the Landscape and Dynamics of CD32a
    Coindre S; Tchitchek N; Alaoui L; Vaslin B; Bourgeois C; Goujard C; Avettand-Fenoel V; Lecuroux C; Bruhns P; Le Grand R; Beignon AS; Lambotte O; Favier B;
    Front Immunol; 2018; 9():1217. PubMed ID: 29915583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor functional immune recovery in aged HIV-1-infected patients following successfully treatment with antiretroviral therapy.
    Kasahara TM; Hygino J; Andrade RM; Monteiro C; Sacramento PM; Andrade AF; Bento CA
    Hum Immunol; 2015 Oct; 76(10):701-10. PubMed ID: 26429325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.